Lisa Mary Raven
@lisamaryraven
Followers
141
Following
620
Media
45
Statuses
142
Endocrinologist | PhD Candidate | Conjoint Lecturer @GarvanInstitute @UNSWMedicine @SVHSydney *tweets are my own
Sydney, Australia
Joined November 2012
A heartfelt thanks to the @heartfoundation & @radicalseven2 for the support of my PhD research! Very honoured & excited to start our trial at @GarvanInstitute @UNSWMedicine @SVHSydney ❤️💊.
Congrats to @lisamaryraven who was awarded a 2022 PhD Scholarship to show how medicines can have an effect on diabetes & heart function following heart transplant. Funding is generously supported by Heart Foundation board member Rebecca Davies AO @GarvanInstitute @radicalseven2
3
5
39
RT @AUDiabetesSoc: Calling all early career ADS members attending #24ADC! Join us for an exclusive half-day workshop on Tuesday, 20 August….
0
1
0
0
1
7
Grateful for the opportunity to present some of my PhD research on #SGLT2 inhibitor use prior to #hearttransplant at #ISHLT2024 @ISHLT
0
1
14
RT @EndoSocAus: On #InternationalWomensDay we reflect on research by our President @ann_mccorm and Women in Endocrinology Chair @lisamaryra….
0
1
0
#InternationalWomensDay at @SVHSydney with some takeaways 🗣️turn up and speak up 💥 don’t undermine ⏩ fight forward 📣 be the voice for women who can’t be there
1
0
5
A topical and complex issue with the rise of #GLP1RA use - more research is needed!.
Considerations of delayed gastric emptying with peri‐operative use of glucagon‐like peptide‐1 receptor agonists. Read the article:
0
1
6
RT @theMJA: Considerations of delayed gastric emptying with peri‐operative use of glucagon‐like peptide‐1 receptor agonists. Read the artic….
0
1
0
Please to share our review of early post transplant hyperglycaemia and diabetes following heart 🫀 transplantation 🏥 @tandfonline @SVHSydney @UNSWMedicine .
0
2
11
Thanks for highlighting our presentation on fertility, childbearing and early parenting experience of doctors at @ESASRB @EndoSocAus - stay tuned for the manuscript in the works 👩⚕️🤰.
Rigid speciality training programs mean female doctors can’t have it all - at least not without delaying childbearing, prioritising work over their fertility & then dropping back on work to provide the major share of childcare🤹♀️ @lisamaryraven #ESASRB23.
0
1
10
Our case of #SGLT2 inhibitor associated ketoacidosis in a patient without diabetes. These medications have so many benefits 🫀🫘🏥 but pharmacovigilance is also important @SVHSydney @GarvanInstitute @VictorChangInst.
Ketoacidosis is a known risk of SGLT2i use in diabetes. We describe one of the first cases of SGLT2i ketoacidosis in a patient without diabetes, receiving treatment for cardiac failure. @ADA_Pubs . Read Here➡️
0
2
9
Was an honour to be invited to speak as part of the @ESASRB ECR Career Development Workshop @EndoSocAus with @drjojames @AJ_Pask
0
1
18
An excellent presentation by Dr Nele Lenders from @GarvanInstitute with PhD supervisor @ann_mccorm in the @EndoSocAus Bryan Hudson Award session 👏🏻👏🏻 at @ESASRB
1
4
13
A packed session with A/Prof Sunita De Sousa @UniofAdelaide presenting an update on #prolactinoma guidelines at @ESASRB with @EndoSocAus President @ann_mccorm promoting discussion #ESASRB23
1
1
16
RT @EndoSocAus: Thank you to Dr @emilykatebrooks & Dr Anjana Radhakutty for organising an amazing Clinical Weekend, and to our invited plen….
0
1
0
RT @EndoSocAus: Less than a week to go until #ESASRB23 - we can’t wait to see you there! Last chance to register!
0
4
0
One of the first cases of #SGLT2 inhibitor associated ketoacidosis in a patient without diabetes. These medications are amazing 🫀💊🩺 but pharmacovigilance is also important. Collaboration from @SVHSydney @GarvanInstitute.
Recently Published: SGLT2 Inhibitor-Induced Ketoacidosis in a Patient Without Diabetes
0
1
7
RT @VictorChangInst: Recently Published: SGLT2 Inhibitor-Induced Ketoacidosis in a Patient Without Diabetes
0
1
0
RT @thuy_tweets_: @lisamaryraven presenting at our annual #svshipresearchweek2023 👏👏👏 @SVHSydney @UNSWMedicine @GarvanInstitute @SVCRSympos….
0
3
0